In June 2024, the Company announced a plan to reduce its global headcount by approximately 17% of the Company’s total number of employees prior to the reduction (the “2024 headcount reduction”). This action was taken consistent with the Company’s ongoing focus on aligning its resources to the market opportunity, improving operational efficiency, and supporting the long-term growth of the business.

As a result of the 2024 headcount reduction, the Company recognized costs for one-time employee termination benefits consisting of severance and other employee-related costs. The Company also recognized a stock-based compensation benefit primarily related to the reversal of previously recognized stock-based compensation expenses for unvested stock awards. A summary of the restructuring charges recognized during the fiscal year ended January 31, 2025 is provided in the tables below:


(in thousands)	Severance and Other Employee Costs		Stock-Based Compensation			Total
Cost of revenue	$	1,322	$	(176	)	$	1,146
Research and development		3,461		(427	)		3,034
Sales and marketing		4,506		(721	)		3,785
General and administrative		1,285		(71	)		1,214
Total restructuring charges	$	10,574	$	(1,395	)	$	9,179

There were no restructuring charges recognized during the fiscal year ended January 31, 2026. The 2024 headcount reduction, including cash payments, was substantially complete as of January 31, 2025.

In August 2023, the Company announced a plan to reduce its global headcount by approximately 10% of the Company’s total number of employees prior to the reduction (the “2023 headcount reduction”). This action was taken to increase the Company’s focus on its high priority growth opportunities and operational efficiency.

As a result of the 2023 headcount reduction, the Company recognized costs for one-time employee termination benefits consisting of severance and other employee-related costs. The Company also recognized a stock-based compensation benefit primarily related to the reversal of previously recognized stock-based compensation expenses for unvested stock awards. A summary of the restructuring charges recognized during the fiscal year ended January 31, 2024 is provided in the table below:


(in thousands)	Severance and Other Employee Costs		Stock-Based Compensation			Total
Cost of revenue	$	564	$	(62	)	$	502
Research and development		3,306		(398	)		2,908
Sales and marketing		1,943		(815	)		1,128
General and administrative		1,563		(253	)		1,310
Total restructuring charges	$	7,376	$	(1,528	)	$	5,848

There were no restructuring charges recognized during the fiscal years ended January 31, 2026 and 2025 related to the 2023 headcount reduction. The 2023 headcount reduction, including cash payments, was complete as of January 31, 2024.